A cross-sectional, multi-centre, epidemiological study to estimate the burden of respiratory syncytial virus (RSV) infection in adults aged >- 60 years, presenting with acute respiratory infection (ARI) at outpatient clinics / outpatient hospitals in Japan.

Katsumata Masayuki0 个研究点目标入组 3,000 人开始时间: 2021年7月12日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•A male or female aged >- 60 years at onset of ARI.
•- Participants diagnosed with at least 2 ARI symptoms/signs meeting the ARI case definition, for at least 24 hours, and an onset date of first symptom/sign less than 10 days before the medical visit at an outpatient clinic/outpatient hospital.
•- Participants who in the opinion of the investigator, can and will comply with the requirements of the study procedures (e.g. agree to provide nasal and throat swab samples, complete self-administered questionnaires, attend regular phone calls, etc.).
•- Participants who are able to provide written informed consent.

•- History of vaccination with an investigational RSV vaccine and administration of any RSV drugs or planned administration, anytime during the study period.
•Note: Any RSV drug includes any investigational, preventative or curative drug targeting RSV specifically (including biological products such as vaccines).
•- Participants with a known cognitive impairment (based on the medical judgement of the investigator).
•- Re-enrolment if new ARI symptoms/signs are reported within 7 days from the resolution of the previous ARI or before study conclusion of the previous ARI episode.

发起方

Katsumata Masayuki